These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 31158837

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Mitry D, Bunce C, Charteris D.
    Cochrane Database Syst Rev; 2013 Jan 31; (1):CD009510. PubMed ID: 23440840
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A meta-analysis of patients with treatment-resistant macular oedema secondary to retinal vein occlusions following switching to aflibercept.
    Spooner K, Hong T, Bahrami B, Chang A.
    Acta Ophthalmol; 2019 Feb 31; 97(1):15-23. PubMed ID: 30251325
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison between ranibizumab and aflibercept for macular edema associated with central retinal vein occlusion.
    Saishin Y, Ito Y, Fujikawa M, Sawada T, Ohji M.
    Jpn J Ophthalmol; 2017 Jan 31; 61(1):67-73. PubMed ID: 27660163
    [Abstract] [Full Text] [Related]

  • 13. Comparative effectiveness and harms of intravitreal antivascular endothelial growth factor agents for three retinal conditions: a systematic review and meta-analysis.
    Low A, Faridi A, Bhavsar KV, Cockerham GC, Freeman M, Fu R, Paynter R, Kondo K, Kansagara D.
    Br J Ophthalmol; 2019 Apr 31; 103(4):442-451. PubMed ID: 30409915
    [Abstract] [Full Text] [Related]

  • 14. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
    Virgili G, Parravano M, Evans JR, Gordon I, Lucenteforte E.
    Cochrane Database Syst Rev; 2018 Oct 16; 10(10):CD007419. PubMed ID: 30325017
    [Abstract] [Full Text] [Related]

  • 15. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
    Virgili G, Parravano M, Evans JR, Gordon I, Lucenteforte E.
    Cochrane Database Syst Rev; 2017 Jun 22; 6(6):CD007419. PubMed ID: 28639415
    [Abstract] [Full Text] [Related]

  • 16. Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.
    Hykin P, Prevost AT, Sivaprasad S, Vasconcelos JC, Murphy C, Kelly J, Ramu J, Alshreef A, Flight L, Pennington R, Hounsome B, Lever E, Metry A, Poku E, Yang Y, Harding SP, Lotery A, Chakravarthy U, Brazier J.
    Health Technol Assess; 2021 Jun 22; 25(38):1-196. PubMed ID: 34132192
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of initial visual acuity on anti-VEGF treatment outcomes in patients with macular oedema secondary to retinal vein occlusions in routine clinical practice.
    Wai KM, Khan M, Srivastava S, Rachitskaya A, Silva FQ, Deasy R, Schachat AP, Babiuch A, Ehlers JP, Kaiser PK, Yuan A, Singh RP.
    Br J Ophthalmol; 2017 May 22; 101(5):574-579. PubMed ID: 27503394
    [Abstract] [Full Text] [Related]

  • 20. A randomised, double-masked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal vein occlusion: MARVEL Report No. 1.
    Narayanan R, Panchal B, Das T, Chhablani J, Jalali S, Ali MH, MARVEL study group.
    Br J Ophthalmol; 2015 Jul 22; 99(7):954-9. PubMed ID: 25631483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.